Tag: Clerkenwell Health - Psychedelic Alpha

Read more about the article Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership

Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership

Post published:May 11, 2023
Post category:Press Release

Read more about the article Former Compass Interim Clinical Sciences Director Joins Clerkenwell Health as CMO

Former Compass Interim Clinical Sciences Director Joins Clerkenwell Health as CMO

Post published:September 16, 2021
Post category:Press Release

Read more about the article Clerkenwell Signs First Multi-million Pound Contract with International Psychedelic Bio-tech Company

Clerkenwell Signs First Multi-million Pound Contract with International Psychedelic Bio-tech Company

Post published:July 7, 2021
Post category:Press Release

Read more about the article UK Set to Become Hub of Psychedelic Research, as British Startup Gears-up to Run Trials for International Psychedelic Drug Developers

UK Set to Become Hub of Psychedelic Research, as British Startup Gears-up to Run Trials for International Psychedelic Drug Developers

Post published:June 25, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.